How the Liver Makes Fat: And Why It’s Harder to Stop Than We Thought
Most people assume that sugar is the main driver of fat production in the liver. Cut carbs, reduce fat—simple, right?
Not quite.
A new study in Cell Metabolism reveals that the liver has a surprisingly flexible system for making fat. Instead of relying on a single fuel source, it uses a layered network of pathways—and when one is blocked, others step in to keep production going.
Why Liver Fat Production Matters
De novo lipogenesis (DNL) is the process by which the liver converts nutrients into fat. While essential for normal physiology, excessive DNL is strongly linked to:
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
- Insulin resistance
- Cardiometabolic risk
Previous work has shown that elevated DNL contributes directly to fatty liver and metabolic disease progression [2][3].
The Primary Pathway: Carbohydrates → Fat
Under typical conditions, the liver primarily uses carbohydrate-derived pyruvate to make fat:
- Glucose → pyruvate
- Pyruvate enters mitochondria
- Converted into citrate
- Exported and converted into acetyl-CoA
- Acetyl-CoA feeds fatty acid synthesis
This pathway is controlled by key enzymes:
- MPC (mitochondrial pyruvate carrier)
- ACLY (ATP-citrate lyase)
Together, they act as gatekeepers of the dominant fat-production route.
This model aligns with earlier work showing that glucose and circulating lactate are major contributors to the TCA cycle and lipogenesis [4].
Parallel Pathway: Acetate
The liver can also use acetate, derived from:
- Diet (e.g., ethanol metabolism)
- Gut microbiota fermentation
Acetate is converted directly into acetyl-CoA via ACSS2, bypassing mitochondrial steps.
However, the study shows that:
- This pathway operates in parallel, not as a full backup
- It does not significantly compensate when the main pathway is disrupted
This supports earlier findings that microbiota-derived acetate can contribute to lipogenesis, but within limits [5].
The Hidden Backup: Ketones
The most surprising finding is the role of ketones.
When the main citrate pathway is disrupted:
- The liver increases fat production from acetoacetate (a ketone body)
- This process depends on the enzyme AACS
- Ketones can also be derived from leucine metabolism
This pathway becomes strongly upregulated under metabolic stress.
Historically, ketones have been known to support lipid synthesis [6][7], but this study shows they function as a reciprocal system—stepping in when citrate-based pathways fail.
How the Study Revealed This Network
The researchers used:
- ¹³C isotope tracing to follow carbon through metabolic pathways
- Genetic knockout mouse models to disable specific enzymes
This allowed them to directly measure how different substrates (pyruvate, acetate, ketones) contribute to fat synthesis.
Stable isotope tracing has become a cornerstone of metabolic research, enabling precise flux analysis across pathways [8].
Key Insight: Metabolic Flexibility
The central discovery is simple but powerful:
The liver doesn’t stop making fat when one pathway is blocked—it switches fuel sources.
This reveals a hierarchical network:
- Primary: Pyruvate → citrate → acetyl-CoA
- Parallel: Acetate → acetyl-CoA
- Backup/reciprocal: Ketones → acetyl-CoA
Implications for Disease and Treatment
This flexibility helps explain why many therapies targeting fat production have limited success:
- Blocking downstream enzymes (e.g., ACC, FASN) can cause side effects
- Targeting one upstream pathway may trigger compensation via others
Emerging therapies targeting enzymes like ACLY (e.g., bempedoic acid) show promise but may still be influenced by these network effects [9].
Future strategies may need to:
- Target multiple pathways simultaneously
- Consider dietary and metabolic context
- Account for adaptive rerouting
The Critical Role of Isotope Tracing
This level of insight is only possible with high-quality stable isotope tools.
By using ¹³C-labelled substrates, researchers can:
- Quantify contributions of different nutrients
- Track metabolic flux in real time
- Reveal hidden compensatory pathways
Such approaches are essential for advancing our understanding of metabolism in health and disease.
Enabling Discovery with Cambridge Isotope Laboratories
Reliable isotope tracing depends on precision and purity.
Cambridge Isotope Laboratories (CIL) provides:
- ¹³C-labeled glucose, acetate, amino acids, and ketone precursors
- Deuterated compounds for metabolic and pharmacokinetic studies
- Custom labelling solutions tailored to complex experimental designs
These tools empower researchers to:
- Perform high-resolution metabolic flux analysis
- Investigate disease mechanisms at a systems level
- Accelerate translational and therapeutic research
Conclusion: A Flexible System, Not a Single Pathway
This study fundamentally reshapes our understanding of how the liver produces fat. Rather than relying on a single, dominant pathway, hepatic lipogenesis operates as a flexible, interconnected network that can adapt when one route is disrupted.
While the MPC–ACLY pathway remains the primary driver under normal conditions, the liver can shift to alternative fuels—most notably ketones and amino acids like leucine—to sustain fat production when needed. This adaptability likely evolved as a survival mechanism but may also contribute to excessive fat accumulation in modern metabolic disease.
The key implication is clear:
Targeting a single pathway is unlikely to fully suppress liver fat production.
Instead, effective therapeutic strategies will need to account for the liver’s ability to reroute metabolism across multiple substrates and pathways.
Finally, this work highlights the power of stable isotope tracing in uncovering complex metabolic interactions. By mapping how nutrients flow through the system, researchers can reveal hidden compensatory mechanisms—insights that are essential for developing more precise and effective interventions.
In short, controlling liver fat will require thinking beyond single targets and embracing metabolism as a dynamic, adaptive system.